Bristol Myers BMY announced that the European Commission (EC) has approved the blockbuster immuno-oncology drug Opdivo ...

The panelist discusses how for patients initially eligible for embolization, systemic therapy may be combined with ...

Liver cancer in the Philippines holds a staggering mortality rate of 11.6 out of 100,000 individuals, compared to the global death rate of 7.8/100,000. This reflects the significant impact of liver ...

Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...

Department of Gastroenterology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan Department of Clinical and Molecular Genetics, Hiroshima University, ...

This is encouraging as AFP is a liver cancer biomarker where high AFP ... About primary liver cancer Primary liver cancer is the third leading cause of cancer-related deaths worldwide. Hepatocellular ...

Table 2. Research literature on the development and validation of risk models for hepatocellular carcinoma (HCC) in hepatitis B virus (HBV)-infected patients. The modeling population of the HCC risk ...

Background: Hepatocellular carcinoma (HCC ... Conventional screening methods, such as ultrasound and alpha-fetoprotein (AFP) testing, have limited sensitivity, particularly for early-stage tumors. The ...

1Division of Hematology/Oncology, University of California, San Francisco, San Francisco, California. 2Quantitative Biosciences Institute, University of California ...

Most of the rest of this information is about hepatocellular carcinoma and will be referred to as liver cancer. About 10% to 20% of liver cancers start in the cells that line the small bile ducts ...